LeMaitre Vascular, Inc.
LMAT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $61 | $64 | $60 | $56 |
| % Growth | -5% | 7.3% | 7.5% | – |
| Cost of Goods Sold | $15 | $19 | $18 | $17 |
| Gross Profit | $46 | $45 | $41 | $39 |
| % Margin | 75.3% | 70% | 69.2% | 69.3% |
| R&D Expenses | $3 | $4 | $4 | $4 |
| G&A Expenses | $11 | $10 | $10 | $9 |
| SG&A Expenses | $23 | $25 | $25 | $22 |
| Sales & Mktg Exp. | $12 | $15 | $14 | $13 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $26 | $29 | $29 | $26 |
| Operating Income | $20 | $16 | $13 | $13 |
| % Margin | 33.3% | 25.1% | 21.1% | 23.1% |
| Other Income/Exp. Net | $2 | $2 | $2 | $1 |
| Pre-Tax Income | $23 | $18 | $14 | $14 |
| Tax Expense | $5 | $4 | $3 | $3 |
| Net Income | $17 | $14 | $11 | $11 |
| % Margin | 28.4% | 21.5% | 18.4% | 20.1% |
| EPS | 0.77 | 0.61 | 0.49 | 0.5 |
| % Growth | 26.2% | 24.5% | -2% | – |
| EPS Diluted | 0.75 | 0.6 | 0.48 | 0.49 |
| Weighted Avg Shares Out | 23 | 23 | 23 | 23 |
| Weighted Avg Shares Out Dil | 24 | 23 | 23 | 23 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $3 | $3 | $2 |
| Interest Expense | $1 | $1 | $1 | $0 |
| Depreciation & Amortization | $3 | $3 | $3 | $2 |
| EBITDA | $26 | $22 | $18 | $20 |
| % Margin | 43.4% | 34.3% | 30.2% | 36.2% |